GMP 2021 Symposium
Personalized Medicine: How far are we?
Amin Rostami, PhD, Chief Scientific Officer, Certara UK, F. Dayan/ExactCure, C. Pallaud/Novartis, J. Turgeon/TabulaRasa HealthCare
Targeting the right treatment for the right patient at the right dose and time is now becoming a reality thanks to the new tools available. In this session will see how liquid biopsies, pharmacogenomics, biomarkers, modeling and digital tools can reach the target of such a personalized medicine to accelerate drug development and improve the drug efficacy and safety of marketed drugs.